Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
C8688 Anlotinib (hydrochloride)Summary: A tyrosine kinase inhibitor -
C8694 PLX5622 hemifumarateSummary: A CSF1R inhibitor -
B8533 SUN11602Summary: A novel basic aniline compound with fibroblast growth factor activity -
BA1266 SucralfateSummary: Sucralfate(Sucroseocta sulfate-aluminum complex) -
C3590 MitoPQSummary: A mitochondria-targeted Complex I redox-cycling reagent that increases superoxide production. -
C3715 Cyclic GMP (sodium salt)Summary: A widely present second messenger that mediates cellular signal transduction and physiological effects. -
C5087 6'-Sialyllactose (sodium salt)Summary: Able to inhibit the internalization of Pseudomonas aeruginosa into lung cells. -
C5177 NBI 31772Summary: A non-selective IGFBP inhibitor with neuroprotective and pro-chondrogenic synthesis effects. -
C5309 GTP 14564Summary: A guanosine triphosphate analog used to study GTP-mediated signal transduction mechanisms. -
C8772 Toceranib phosphateSummary: Toceranib phosphate is a multitarget receptor tyrosine kinase inhibitor targeting PDGFR, VEGFR, and Kit, utilized in oncology, angiogenesis, and signal-transduction research.
